Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease

D. L. Bowton, D. A. Stump, Donald Prough, J. F. Toole, D. S. Lefkowitz, L. Coker

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

We determined the immediate effects of pentoxifylline on cerebral blood flow in 10 patients with cerebrovascular disease; four received 400 mg and six received 800 mg pentoxifylline orally. Regional cerebral blood flow was measured before (baseline) and 2, 4, and 6 hours after pentoxifylline administration using the xenon-133 clearance technique with 16 detectors (eight per hemisphere). Global cerebral blood flow as a percentage of the baseline value increased significantly after 800 mg but not 400 mg pentoxifylline (p=0.017 and p=0.29, respectively). Regional cerebral blood flow as a percentage of the baseline value at the detector with the lowest baseline value increased significantly 2 hours after both 400 mg and 800 mg pentoxifylline (p=0.038 and p=0.010, respectively). Cerebrovascular reactivity to carbon dioxide was preserved despite the increases in cerebral blood flow. Pentoxifylline increases cerebral blood flow and is not associated with 'intracerebral steal' in patients with cerebrovascular disease.

Original languageEnglish (US)
Pages (from-to)1662-1666
Number of pages5
JournalStroke
Volume20
Issue number12
StatePublished - 1989
Externally publishedYes

Fingerprint

Cerebrovascular Circulation
Cerebrovascular Disorders
Pentoxifylline
Regional Blood Flow
Xenon
Carbon Dioxide

Keywords

  • Cerebral blood flow
  • pentoxifylline
  • xenon

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Cite this

Bowton, D. L., Stump, D. A., Prough, D., Toole, J. F., Lefkowitz, D. S., & Coker, L. (1989). Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease. Stroke, 20(12), 1662-1666.

Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease. / Bowton, D. L.; Stump, D. A.; Prough, Donald; Toole, J. F.; Lefkowitz, D. S.; Coker, L.

In: Stroke, Vol. 20, No. 12, 1989, p. 1662-1666.

Research output: Contribution to journalArticle

Bowton, DL, Stump, DA, Prough, D, Toole, JF, Lefkowitz, DS & Coker, L 1989, 'Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease', Stroke, vol. 20, no. 12, pp. 1662-1666.
Bowton DL, Stump DA, Prough D, Toole JF, Lefkowitz DS, Coker L. Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease. Stroke. 1989;20(12):1662-1666.
Bowton, D. L. ; Stump, D. A. ; Prough, Donald ; Toole, J. F. ; Lefkowitz, D. S. ; Coker, L. / Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease. In: Stroke. 1989 ; Vol. 20, No. 12. pp. 1662-1666.
@article{c1640531bc5247a18daf4375464da675,
title = "Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease",
abstract = "We determined the immediate effects of pentoxifylline on cerebral blood flow in 10 patients with cerebrovascular disease; four received 400 mg and six received 800 mg pentoxifylline orally. Regional cerebral blood flow was measured before (baseline) and 2, 4, and 6 hours after pentoxifylline administration using the xenon-133 clearance technique with 16 detectors (eight per hemisphere). Global cerebral blood flow as a percentage of the baseline value increased significantly after 800 mg but not 400 mg pentoxifylline (p=0.017 and p=0.29, respectively). Regional cerebral blood flow as a percentage of the baseline value at the detector with the lowest baseline value increased significantly 2 hours after both 400 mg and 800 mg pentoxifylline (p=0.038 and p=0.010, respectively). Cerebrovascular reactivity to carbon dioxide was preserved despite the increases in cerebral blood flow. Pentoxifylline increases cerebral blood flow and is not associated with 'intracerebral steal' in patients with cerebrovascular disease.",
keywords = "Cerebral blood flow, pentoxifylline, xenon",
author = "Bowton, {D. L.} and Stump, {D. A.} and Donald Prough and Toole, {J. F.} and Lefkowitz, {D. S.} and L. Coker",
year = "1989",
language = "English (US)",
volume = "20",
pages = "1662--1666",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease

AU - Bowton, D. L.

AU - Stump, D. A.

AU - Prough, Donald

AU - Toole, J. F.

AU - Lefkowitz, D. S.

AU - Coker, L.

PY - 1989

Y1 - 1989

N2 - We determined the immediate effects of pentoxifylline on cerebral blood flow in 10 patients with cerebrovascular disease; four received 400 mg and six received 800 mg pentoxifylline orally. Regional cerebral blood flow was measured before (baseline) and 2, 4, and 6 hours after pentoxifylline administration using the xenon-133 clearance technique with 16 detectors (eight per hemisphere). Global cerebral blood flow as a percentage of the baseline value increased significantly after 800 mg but not 400 mg pentoxifylline (p=0.017 and p=0.29, respectively). Regional cerebral blood flow as a percentage of the baseline value at the detector with the lowest baseline value increased significantly 2 hours after both 400 mg and 800 mg pentoxifylline (p=0.038 and p=0.010, respectively). Cerebrovascular reactivity to carbon dioxide was preserved despite the increases in cerebral blood flow. Pentoxifylline increases cerebral blood flow and is not associated with 'intracerebral steal' in patients with cerebrovascular disease.

AB - We determined the immediate effects of pentoxifylline on cerebral blood flow in 10 patients with cerebrovascular disease; four received 400 mg and six received 800 mg pentoxifylline orally. Regional cerebral blood flow was measured before (baseline) and 2, 4, and 6 hours after pentoxifylline administration using the xenon-133 clearance technique with 16 detectors (eight per hemisphere). Global cerebral blood flow as a percentage of the baseline value increased significantly after 800 mg but not 400 mg pentoxifylline (p=0.017 and p=0.29, respectively). Regional cerebral blood flow as a percentage of the baseline value at the detector with the lowest baseline value increased significantly 2 hours after both 400 mg and 800 mg pentoxifylline (p=0.038 and p=0.010, respectively). Cerebrovascular reactivity to carbon dioxide was preserved despite the increases in cerebral blood flow. Pentoxifylline increases cerebral blood flow and is not associated with 'intracerebral steal' in patients with cerebrovascular disease.

KW - Cerebral blood flow

KW - pentoxifylline

KW - xenon

UR - http://www.scopus.com/inward/record.url?scp=0024836286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024836286&partnerID=8YFLogxK

M3 - Article

C2 - 2512690

AN - SCOPUS:0024836286

VL - 20

SP - 1662

EP - 1666

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 12

ER -